Related references
Note: Only part of the references are listed.Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: A multi-institutional study
Romain Mathieu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
Morgan Roupret et al.
EUROPEAN UROLOGY (2013)
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
David A. Green et al.
JOURNAL OF UROLOGY (2013)
Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours
David R. Yates et al.
WORLD JOURNAL OF UROLOGY (2013)
The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy
Thomas F. Chromecki et al.
EUROPEAN UROLOGY (2012)
Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Eugene K. Cha et al.
EUROPEAN UROLOGY (2012)
Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma
Michael Rink et al.
EUROPEAN UROLOGY (2012)
Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
Giovanni Lughezzani et al.
EUROPEAN UROLOGY (2012)
Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch
Bangmin Han et al.
WORLD JOURNAL OF UROLOGY (2012)
Immune expression of E-cadherin and α, β and γ-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas
Sabrina Thalita dos Reis et al.
INTERNATIONAL BRAZ J UROL (2012)
Prognostic factors for upper urinary tract urothelial carcinoma
Thomas F. Chromecki et al.
NATURE REVIEWS UROLOGY (2011)
Expression Profile of E-cadherin and N-cadherin in Urothelial Carcinoma of the Upper Urinary Tract is Associated with Disease Recurrence in Patients Undergoing Nephroureterectomy
Mototsugu Muramaki et al.
UROLOGY (2011)
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients
Wolfgang Otto et al.
WORLD JOURNAL OF UROLOGY (2011)
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
Shahrokh F. Shariat et al.
BJU INTERNATIONAL (2010)
Expression of Snail in Upper Urinary Tract Urothelial Carcinoma: Prognostic Significance and Implications for Tumor Invasion
Takeo Kosaka et al.
CLINICAL CANCER RESEARCH (2010)
Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract
Richard Zigeuner et al.
EUROPEAN UROLOGY (2010)
Cadherin Switching and Bladder Cancer
Richard T. Bryan et al.
JOURNAL OF UROLOGY (2010)
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients
Mesut Remzi et al.
BJU INTERNATIONAL (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
The cell-cell adhesion molecule E-cadherin
F. van Roy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Cadherin switching dictates the biology of transitional cell carcinoma of the bladder:: ex vivo and in vitro studies
R. T. Bryan et al.
JOURNAL OF PATHOLOGY (2008)
Challenges of cancer biomarker profiling
Karim Bensalah et al.
EUROPEAN UROLOGY (2007)
The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma
Fikret Erdemir et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2007)
Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors
Egbert Baumgart et al.
CLINICAL CANCER RESEARCH (2007)
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy
Jose A. Karam et al.
LANCET ONCOLOGY (2007)
N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors
I Lascombe et al.
CLINICAL CANCER RESEARCH (2006)
Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer - Identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors
A Clairotte et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma
G Fromont et al.
EUROPEAN UROLOGY (2005)
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup
RA Byrne et al.
JOURNAL OF UROLOGY (2001)
E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder
SF Shariat et al.
UROLOGY (2001)
Share Paper
